DexCom Cash on Hand 2011-2025 | DXCM
DexCom cash on hand from 2011 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- DexCom cash on hand for the quarter ending September 30, 2025 was $3.322B, a 33.29% increase year-over-year.
- DexCom cash on hand for 2024 was $2.579B, a 5.31% decline from 2023.
- DexCom cash on hand for 2023 was $2.724B, a 10.91% increase from 2022.
- DexCom cash on hand for 2022 was $2.456B, a 10.07% decline from 2021.
|
DexCom Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $2,579 |
| 2023 | $2,724 |
| 2022 | $2,456 |
| 2021 | $2,731 |
| 2020 | $2,708 |
| 2019 | $1,533 |
| 2018 | $1,386 |
| 2017 | $549 |
| 2016 | $124 |
| 2015 | $115 |
| 2014 | $84 |
| 2013 | $55 |
| 2012 | $49 |
| 2011 | $82 |
| 2010 | $48 |
|
DexCom Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-09-30 | $3,322 |
| 2025-06-30 | $2,929 |
| 2025-03-31 | $2,701 |
| 2024-12-31 | $2,579 |
| 2024-09-30 | $2,492 |
| 2024-06-30 | $3,121 |
| 2024-03-31 | $2,897 |
| 2023-12-31 | $2,724 |
| 2023-09-30 | $3,240 |
| 2023-06-30 | $3,636 |
| 2023-03-31 | $2,567 |
| 2022-12-31 | $2,456 |
| 2022-09-30 | $2,372 |
| 2022-06-30 | $2,755 |
| 2022-03-31 | $2,688 |
| 2021-12-31 | $2,731 |
| 2021-09-30 | $2,698 |
| 2021-06-30 | $2,585 |
| 2021-03-31 | $2,633 |
| 2020-12-31 | $2,708 |
| 2020-09-30 | $2,604 |
| 2020-06-30 | $2,509 |
| 2020-03-31 | $1,511 |
| 2019-12-31 | $1,533 |
| 2019-09-30 | $1,430 |
| 2019-06-30 | $1,378 |
| 2019-03-31 | $1,358 |
| 2018-12-31 | $1,386 |
| 2018-09-30 | $669 |
| 2018-06-30 | $606 |
| 2018-03-31 | $534 |
| 2017-12-31 | $549 |
| 2017-09-30 | $526 |
| 2017-06-30 | $497 |
| 2017-03-31 | $181 |
| 2016-12-31 | $124 |
| 2016-09-30 | $127 |
| 2016-06-30 | $116 |
| 2016-03-31 | $107 |
| 2015-12-31 | $115 |
| 2015-09-30 | $113 |
| 2015-06-30 | $98 |
| 2015-03-31 | $84 |
| 2014-12-31 | $84 |
| 2014-09-30 | $75 |
| 2014-06-30 | $61 |
| 2014-03-31 | $57 |
| 2013-12-31 | $55 |
| 2013-09-30 | $48 |
| 2013-06-30 | $46 |
| 2013-03-31 | $45 |
| 2012-12-31 | $49 |
| 2012-09-30 | $53 |
| 2012-06-30 | $61 |
| 2012-03-31 | $70 |
| 2011-12-31 | $82 |
| 2011-09-30 | $97 |
| 2011-06-30 | $106 |
| 2011-03-31 | $39 |
| 2010-12-31 | $48 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $21.451B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $215.059B | 25.55 |
| Intuitive Surgical (ISRG) | United States | $200.747B | 78.54 |
| IDEXX Laboratories (IDXX) | United States | $56.571B | 56.18 |
| Edwards Lifesciences (EW) | United States | $48.391B | 32.45 |
| Alcon (ALC) | Switzerland | $36.485B | 24.49 |
| IQVIA Holdings (IQV) | United States | $35.841B | 19.99 |
| Mettler-Toledo (MTD) | United States | $29.649B | 34.40 |
| STERIS (STE) | Ireland | $25.888B | 26.72 |
| Waters (WAT) | United States | $22.128B | 29.27 |
| Hologic (HOLX) | United States | $16.481B | 17.35 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.721B | 0.00 |
| Globus Medical (GMED) | United States | $11.330B | 23.57 |
| Penumbra (PEN) | United States | $10.425B | 73.33 |
| Masimo (MASI) | United States | $7.690B | 24.64 |
| Sysmex ADR (SSMXY) | Japan | $6.698B | 21.28 |
| Teleflex (TFX) | United States | $4.835B | 7.70 |
| Glaukos (GKOS) | United States | $4.816B | 0.00 |
| TransMedics (TMDX) | United States | $4.073B | 48.25 |
| Veracyte (VCYT) | United States | $3.296B | 37.57 |
| Alphatec Holdings (ATEC) | United States | $2.941B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.755B | 14.88 |
| Integer Holdings (ITGR) | United States | $2.392B | 11.23 |
| Artivion (AORT) | United States | $2.117B | 97.54 |
| Nihon Kohden (NHNKY) | Japan | $2.067B | 24.67 |
| PROCEPT BioRobotics (PRCT) | United States | $1.784B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.686B | 16.34 |
| Beta Bionics (BBNX) | United States | $1.158B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.099B | 0.00 |
| AxoGen (AXGN) | United States | $1.087B | 0.00 |
| IRadimed (IRMD) | United States | $1.073B | 51.11 |
| Pulse Biosciences (PLSE) | United States | $1.048B | 0.00 |
| OPKO Health (OPK) | United States | $1.029B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.938B | 5.08 |
| SiBone (SIBN) | United States | $0.680B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.591B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.555B | 32.29 |
| Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.521B | 10.40 |
| AngioDynamics (ANGO) | United States | $0.495B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.449B | 0.00 |
| NeuroPace (NPCE) | United States | $0.437B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.427B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.418B | 11.59 |
| Semler Scientific (SMLR) | United States | $0.418B | 3.28 |
| RxSight (RXST) | United States | $0.385B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.327B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.305B | 50.82 |
| Sight Sciences (SGHT) | United States | $0.305B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.294B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.282B | 0.00 |
| 908 Devices (MASS) | United States | $0.265B | 0.00 |
| CVRx (CVRX) | United States | $0.255B | 0.00 |
| Inogen (INGN) | United States | $0.189B | 0.00 |
| Neuronetics (STIM) | United States | $0.156B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.144B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.144B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.138B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.137B | 0.00 |
| Accuray (ARAY) | United States | $0.133B | 0.00 |
| LENSAR (LNSR) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.106B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.084B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.077B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.076B | 0.00 |
| InspireMD (NSPR) | United States | $0.076B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.060B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.038B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Envoy Medical (COCH) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Solana (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.54 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |